Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)

Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11)

Product description

The present Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO and IL-11) as of April 2013 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11 or other receptors on the market and in development. In addition, the report lists company-specific R&D pipelines of Thrombopoiesis Stimulating Agents (TPO; IL-11). Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects on the market and in research and development of thrombopoiesis stimulating agents for treatment of thrombocytopenia. In addition, the report lists company-specific product portfolios and R&D pipelines of Thrombopoiesis Stimulating Agents (TPO; IL-11). Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.